First Trust Advisors LP acquired a new stake in Adeptus Health Inc. (NYSE:ADPT) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 22,477 shares of the company’s stock, valued at approximately $1,161,000. First Trust Advisors LP owned 0.14% of Adeptus Health as of its most recent filing with the SEC.
Several other large investors also recently made changes to their positions in ADPT. Seven Eight Capital LLC acquired a new stake in Adeptus Health during the first quarter worth $101,000. Royal Bank of Canada increased its stake in Adeptus Health by 1,036.6% in the first quarter. Royal Bank of Canada now owns 2,330 shares of the company’s stock worth $130,000 after buying an additional 2,125 shares in the last quarter. Springbok Capital Management LLC acquired a new stake in Adeptus Health during the first quarter worth $151,000. BNP Paribas Arbitrage SA increased its stake in Adeptus Health by 124.6% in the second quarter. BNP Paribas Arbitrage SA now owns 4,169 shares of the company’s stock worth $215,000 after buying an additional 2,313 shares in the last quarter. Finally, M&T Bank Corp acquired a new stake in Adeptus Health during the first quarter worth $216,000.
Adeptus Health Inc. (NYSE:ADPT) traded down 2.86% on Monday, hitting $41.82. The company had a trading volume of 163,349 shares. Adeptus Health Inc. has a 12-month low of $35.33 and a 12-month high of $90.71. The firm has a market capitalization of $683.76 million, a PE ratio of 6.37 and a beta of 0.96. The firm has a 50-day moving average price of $41.49 and a 200-day moving average price of $52.76.
Adeptus Health (NYSE:ADPT) last posted its quarterly earnings results on Thursday, July 21st. The company reported $0.48 earnings per share for the quarter, missing analysts’ consensus estimates of $0.51 by $0.03. Adeptus Health had a net margin of 22.99% and a return on equity of 14.74%. The business earned $100.20 million during the quarter, compared to the consensus estimate of $93.92 million. During the same quarter last year, the company posted $0.44 EPS. The firm’s revenue was up 36.2% on a year-over-year basis. On average, equities research analysts anticipate that Adeptus Health Inc. will post $2.46 earnings per share for the current fiscal year.
A number of equities research analysts have weighed in on ADPT shares. JMP Securities decreased their price target on shares of Adeptus Health from $94.00 to $92.00 and set a “market outperform” rating on the stock in a research note on Wednesday, August 31st. Jefferies Group reiterated a “buy” rating and set a $100.00 price target (down previously from $113.00) on shares of Adeptus Health in a research note on Monday, July 25th. Goldman Sachs Group Inc. set a $80.00 price target on shares of Adeptus Health and gave the stock a “buy” rating in a research note on Thursday, September 8th. Finally, Zacks Investment Research cut Adeptus Health from a “buy” rating to a “strong sell” rating in a report on Wednesday, July 13th. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $86.50.
Adeptus Health Company Profile
Adeptus Health Inc is a patient-centered healthcare company. The Company is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. The Company has approximately 80 freestanding facilities and over two licensed general hospitals.
Want to see what other hedge funds are holding ADPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adeptus Health Inc. (NYSE:ADPT).
Receive News & Ratings for Adeptus Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adeptus Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.